Epigenetic inactivation of inhibitor of differentiation 4 (Id4) correlates with prostate cancer
Open Access
- 2 August 2012
- journal article
- research article
- Published by Wiley in Cancer Medicine
- Vol. 1 (2) , 176-186
Abstract
The inhibitor of DNA‐binding (Id) proteins, Id1–4 are negative regulators of basic helix‐loop‐helix (bHLH) transcription factors. As key regulators of cell cycle and differentiation, expression of Id proteins are increasingly observed in many cancers and associated with aggressiveness of the disease. Of all the four Id proteins, the expression of Id1, Id2, and to a lesser extent, Id3 in prostate cancer and the underlying molecular mechanism is relatively well known. On the contrary, our previous results demonstrated that Id4 acts as a potential tumor suppressor in prostate cancer. In the present study, we extend these observations and demonstrate that Id4 is down‐regulated in prostate cancer due to promoter hypermethylation. We used prostate cancer tissue microarrays to investigate Id4 expression. Methylation specific PCR on bisulfite treated DNA was used to determine methylation status of Id4 promoter in laser capture micro‐dissected normal, stroma and prostate cancer regions. High Id4 expression was observed in the normal prostate epithelial cells. In prostate cancer, a stage‐dependent decrease in Id4 expression was observed with majority of high grade cancers showing no Id4 expression. Furthermore, Id4 expression progressively decreased in prostate cancer cell line LNCaP and with no expression in androgen‐insensitive LNCaP‐C81 cell line. Conversely, Id4 promoter hypermethylation increased in LNCaP‐C81 cells suggesting epigenetic silencing. In prostate cancer samples, loss of Id4 expression was also associated with promoter hypermethylation. Our results demonstrate loss of Id4 expression in prostate cancer due to promoter hypermethylation. The data strongly support the role of Id4 as a tumor suppressor.Keywords
This publication has 47 references indexed in Scilit:
- Silencing of the inhibitor of DNA binding protein 4 (ID4) contributes to the pathogenesis of mouse and human CLLBlood, 2011
- Inhibitor of differentiation 4 (Id4) is a potential tumor suppressor in prostate cancerBMC Cancer, 2009
- Promoter methylation-associated loss of ID4expression is a marker of tumour recurrence in human breast cancerBMC Cancer, 2008
- t(6;14)(p22;q32): a new recurrent IGH@ translocation involving ID4 in B-cell precursor acute lymphoblastic leukemia (BCP-ALL)Blood, 2008
- Non-redundant inhibitor of differentiation (Id) gene expression and function in human prostate epithelial cellsThe Prostate, 2006
- Id family of helix-loop-helix proteins in cancerNature Reviews Cancer, 2005
- Molecular Features of the Transition from Prostatic Intraepithelial Neoplasia (PIN) to Prostate CancerCancer Research, 2004
- Over Expression of ID-1 in Prostate CancerJournal of Urology, 2002
- Role of Id family proteins in growth controlJournal of Cellular Physiology, 2001
- Molecular Cloning of ID4, a Novel Dominant Negative Helix-Loop-Helix Human Gene on Chromosome 6p21.3-p22Genomics, 1995